Penghua Pharmaceutical Technology Equity Securities Investment Fund (abbreviation: Penghua Pharmaceutical Technology Stock C, code 017900) announced its latest net value on April 14, up 3.15%.
Penghua Pharmaceutical Technology Stock C was established on February 17, 2023, and the performance comparison benchmark is the yield of the CSI Medical and Health Index ×80% + the yield of the total index of China Bond ×20%. The fund has returned 11.18% since its inception, 31.20% this year, 14.68% over the past month, and 26.31% over the past year. In the past year, the fund ranked 522/3506 in its peer group.
The fund manager is Jin Xiaofei. Jin Xiaofei has managed (or intends to manage) the fund since February 17, 2023, with a return of 11.18% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 688235 | BeiGene | 9.58% | 1519355 | 245 million |
| 600276 | Hengrui | 9.10% | 5063482 | 232 million |
| 688428 | InnoCare | 9.04% | 18804913 | 231 million |
| 688192 | Dizhe Pharma | 7.04% | 4332635 | 180 million |
| 688197 | First Pharma Holdings | 6.32% | 5407934 | 161 million |
| 688506 | Baili Tianheng | 5.84% | 777641 | 149 million |
| 603087 | Gan & Lee | Pharmaceuticals 5.61%, | 3246500 | 143 million |
| 688331 | Rongchang Biotech | 5.51% | 4676823 | 141 million |
| 688266 | Zejing Pharmaceuticals | 5.00% | 2047748 | 128 million |
| 688302 | Haichuang Pharmaceuticals | 4.52% | 3761580 | 116 million |
Ticker Name
Percentage Change
Inclusion Date
